Dipna Pharmachem Ltd.
BSE: 543594
₹7.19
₹0.05
(0.70%)
As on 16-Jun-2026 16:01IST
Market cap
₹19 Cr
Revenue (TTM)
₹125 Cr
P/E Ratio
19.4
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
2.6 %
-
ROCE
7 %
-
Industry P/E
39.7
-
EV/EBITDA
9.1
-
Debt to Equity
0.4
-
Book Value
₹16
-
EPS
₹0.4
-
Face value
10
-
Shares outstanding
26,289,250
8 Years Aggregate
CFO
₹-38.33 Cr
EBITDA
₹13.80 Cr
Net Profit
₹4.31 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dipna Pharmachem
| -57.5 | -4.1 | -19.0 | -67.4 | -26.1 | -- | -- |
|
BSE Healthcare
| 8.3 | -0.3 | 9.9 | 6.9 | 23.6 | 13.2 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Dipna Pharmachem
| 15.8 | 60.5 | -47.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dipna Pharmachem
|
7.2 | 18.9 | 124.9 | 1.0 | -- | 2.6 | 19.4 | 0.5 |
| 2,996.5 | 24,561.3 | 1,339.4 | 356.4 | 33.2 | 23.2 | 68.9 | 14.9 | |
| 432.4 | 16,538.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92.3 | 4.2 | |
| 748.4 | 18,536.5 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.2 | 3.6 | |
| 980.0 | 15,707.5 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.4 | 2.2 | |
| 1,599.9 | 18,442.5 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 163.7 | 21,794.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 1,351.6 | 22,053.0 | 1,284.3 | 134.4 | -- | 30.7 | 89.4 | 17.1 | |
| 453.1 | 18,282.2 | 3,738.7 | 316.7 | 12.5 | 7.5 | 57.7 | 3.8 | |
| 1,919.2 | 31,060.4 | 3,373.0 | 199.0 | 12.6 | 5.9 | 145.8 | 6.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Dipna Pharmachem
Trading,exporting,importing of chemicals
-
Incorporated
2011
-
Chairman
--
-
Managing Director
Keyur Shah
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Dipna Pharmachem Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsVoting Results For Postal Ballot
25-May-2026Clarification sought from Dipna Pharmachem Ltd
23-Feb-2026No News & Announcements are available.
FAQs for Dipna Pharmachem
What is the current share price of Dipna Pharmachem Ltd Today?
The share price of Dipna Pharmachem Ltd is ₹7.19 (BSE) as of 16-Jun-2026 16:01 IST. Dipna Pharmachem Ltd has given a return of -26.07% in the last 3 years.
What is the current PB & PE ratio of Dipna Pharmachem Ltd?
The P/E ratio of Dipna Pharmachem Ltd is 19.40 times as on 16-Jun-2026, a 51 discount to its peers’ median range of 39.70 times.
The P/B ratio of Dipna Pharmachem Ltd is 0.46 times as on 16-Jun-2026, a 88 discount to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.30
|
0.89
|
|
2024
|
20.87
|
0.60
|
|
2023
|
13.54
|
0.62
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Dipna Pharmachem Ltd?
The 52-week high and low of Dipna Pharmachem Ltd are Rs 25.66 and Rs 6.66 as of 16-Jun-2026.
What is the market cap of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd has a market capitalisation of ₹ 19 Cr as on 16-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Dipna Pharmachem Ltd?
Before investing in Dipna Pharmachem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.